|
1
|
Farris AB and Colvin RB: Renal
interstitial fibrosis: Mechanisms and evaluation. Curr Opin Nephrol
Hypertens. 21:289–300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Strutz F and Zeisberg M: Renal fibroblasts
and myofibroblasts in chronic kidney disease. J Am Soc Nephrol.
17:2992–2998. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chung AC, Yu X and Lan HY: MicroRNA and
nephropathy: Emerging concepts. Int J Nephrol Renovasc Dis.
6:169–179. 2013.PubMed/NCBI
|
|
7
|
Yuan JL, Tao YY, Wang QL, Shen L and Liu
CH: Fuzheng Huayu Formula () prevents rat renal interstitial
fibrosis induced by HgCl2 via antioxidative stress and
down-regulation of nuclear factor-kappa B activity. Chin J Integr
Med. 23:598–604. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang QL, Tao YY, Yuan JL, Shen L and Liu
CH: Salvianolic acid B prevents epithelial-to-mesenchymal
transition through the TGF-beta1 signal transduction pathway in
vivo and in vitro. BMC Cell Biol. 11:312010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lei Y, Wang QL, Shen L, Tao YY and Liu CH:
MicroRNA-101 suppresses liver fibrosis by downregulating
PI3K/Akt/mTOR signaling pathway. Clin Res Hepatol Gastroenterol.
43:575–584. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang B, Yan Z, Li L, Wang Z and Liu H:
Effect of MiR-101 on rats with CCl4-induced liver fibrosis through
regulating Nrf2-ARE pathway. Panminerva Med. Jul 30–2019.Epub ahead
of print.
|
|
11
|
Huang C, Xiao X, Yang Y, Mishra A, Liang
Y, Zeng X, Yang X, Xu D, Blackburn MR, Henke CA and Liu L:
MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast
proliferation and activation. J Biol Chem. 292:16420–16439. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan Z, Sun X, Shan H, Wang N, Wang J, Ren
J, Feng S, Xie L, Lu C, Yuan Y, et al: MicroRNA-101 inhibited
postinfarct cardiac fibrosis and improved left ventricular
compliance via the FBJ osteosarcoma oncogene/transforming growth
factor-β1 pathway. Circulation. 126:840–850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Zhang S, Wa M, Liu Z and Hu S:
MicroRNA-101 protects against cardiac remodeling following
myocardial infarction via downregulation of runt-related
transcription factor 1. J Am Heart Assoc. 8:e0131122019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang N, Duan L, Ding J, Cao Q, Qian S,
Shen H and Qi J: MicroRNA-101 protects bladder of BOO from
hypoxia-induced fibrosis by attenuating TGF-β-smad2/3 signaling.
IUBMB Life. 71:235–243. 2019.
|
|
15
|
Viart V, Bergougnoux A, Bonini J, Varilh
J, Chiron R, Tabary O, Molinari N, Claustres M and Taulan-Cadars M:
Transcription factors and miRNAs that regulate fetal to adult CFTR
expression change are new targets for cystic fibrosis. Eur Respir
J. 45:116–128. 2015. View Article : Google Scholar
|
|
16
|
Liu Y: Cellular and molecular mechanisms
of renal fibrosis. Nat Rev Nephrol. 7:684–696. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang J and Liu Y: Blockage of tubular
epithelial to myofibroblast transition by hepatocyte growth factor
prevents renal interstitial fibrosis. J Am Soc Nephrol. 13:96–107.
2002. View Article : Google Scholar
|
|
18
|
Allison SJ: Fibrosis: Targeting EMT to
reverse renal fibrosis. Nat Rev Nephrol. 11:5652015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Loeffler I and Wolf G: Transforming growth
factor-beta and the progression of renal disease. Nephrol Dial
Transplant. 29(Suppl 1): i37–i45. 2014. View Article : Google Scholar
|
|
20
|
Iwano M: EMT and TGF-beta in renal
fibrosis. Front Biosci (Schol Ed). 2:229–238. 2010. View Article : Google Scholar
|
|
21
|
Zhao X, Wang K, Liao Y, Zeng Q, Li Y, Hu
F, Liu Y, Meng K, Qian C, Zhang Q, et al: MicroRNA-101a inhibits
cardiac fibrosis induced by hypoxia via targeting TGFβRI on cardiac
fibroblasts. Cell Physiol Biochem. 35:213–226. 2015. View Article : Google Scholar
|
|
22
|
Close B, Banister K, Baumans V, Bernoth
EM, Bromage N, Bunyan J, Erhardt W, Flecknell P, Gregory N,
Hackbarth H, et al: Recommendations for euthanasia of experimental
animals: Part 1. DGXI of the European commission. Lab Anim.
30:293–316. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jamall IS, Finelli VN and Que Hee SS: A
simple method to determine nanogram levels of 4-hydroxyproline in
biological tissues. Anal Biochem. 112:70–75. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article3. 2004. View Article : Google Scholar
|
|
25
|
Joung JG, Hwang KB, Nam JW, Kim SJ and
Zhang BT: Discovery of microRNA-mRNA modules via population-based
probabilistic learning. Bioinformatics. 23:1141–1147. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Iwano M, Plieth D, Danoff TM, Xue C, Okada
H and Neilson EG: Evidence that fibroblasts derive from epithelium
during tissue fibrosis. J Clin Invest. 110:341–350. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tu X, Zhang H and Zhang J, Zhao S, Zheng
X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y and Zhang J: MicroRNA-101
suppresses liver fibrosis by targeting the TGFβ signalling pathway.
J Pathol. 234:46–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meng XM, Chung AC and Lan HY: Role of the
TGF-β/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond).
124:243–254. 2013. View Article : Google Scholar
|
|
30
|
Chaudhary NI, Roth GJ, Hilberg F,
Müller-Quernheim J, Prasse A, Zissel G, Schnapp A and Park JE:
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.
Eur Respir J. 29:976–985. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rudnicki M, Perco PD, Haene B, Leierer J,
Heinzel A, Mühlberger I, Schweibert N, Sunzenauer J, Regele H,
Kronbichler A, et al: Renal microRNA- and RNA-profiles in
progressive chronic kidney disease. Eur J Clin Invest. 46:213–226.
2016. View Article : Google Scholar
|
|
32
|
Wang QL, Yuan JL, Tao YY, Zhang Y, Liu P
and Liu CH: Fuzheng Huayu recipe and vitamin E reverse renal
interstitial fibrosis through counteracting TGF-beta1-induced
epithelial-to-mesenchymal transition. J Ethnopharmacol.
127:631–640. 2010. View Article : Google Scholar
|
|
33
|
Hou X, Tian J, Geng J, Li X, Tang X, Zhang
J and Bai X: MicroRNA-27a promotes renal tubulointerstitial
fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
Oncotarget. 7:47760–47776. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y, Bi X, Xiong J, Han W, Xiao T, Xu X,
Yang K, Liu C, Jiang W, He T, et al: MicroRNA-34a promotes renal
fibrosis by downregulation of klotho in tubular epithelial cells.
Mol Ther. 27:1051–1065. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li H, Xu Y, Zhang Q, Xu H, Xu Y and Ling
K: Microvesicles containing miR-34a induce apoptosis of proximal
tubular epithelial cells and participate in renal interstitial
fibrosis. Exp Ther Med. 17:2310–2316. 2019.PubMed/NCBI
|
|
36
|
Denby L, Ramdas V, Lu R, Conway BR, Grant
JS, Dickinson B, Aurora AB, McClure JD, Kipgen D, Delles C, et al:
MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc
Nephrol. 25:65–80. 2014. View Article : Google Scholar :
|
|
37
|
Zhang J, Jiao J, Cermelli S, Muir K, Jung
KH, Zou R, Rashid A, Gagea M, Zabludoff S, Kalluri R and Beretta L:
miR-21 inhibition reduces liver fibrosis and prevents tumor
development by inducing apoptosis of CD24+ progenitor
cells. Cancer Res. 75:1859–1867. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McClelland AD, Herman-Edelstein M, Komers
R, Jha JC, Winbanks CE, Hagiwara S, Gregorevic P, Kantharidis P and
Cooper ME: miR-21 promotes renal fibrosis in diabetic nephropathy
by targeting PTEN and SMAD7. Clin Sci (Lond). 129:1237–1249. 2015.
View Article : Google Scholar
|
|
39
|
Yuan J, Chen H, Ge D, Xu Y, Xu H, Yang Y,
Gu M, Zhou Y, Zhu J, Ge T, et al: Mir-21 promotes cardiac fibrosis
after myocardial infarction via targeting Smad7. Cell Physiol
Biochem. 42:2207–2219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Carew RM, Wang B and Kantharidis P: The
role of EMT in renal fibrosis. Cell Tissue Res. 347:103–116. 2012.
View Article : Google Scholar
|
|
41
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhao JY, Wang XL, Yang YC, Zhang B and Wu
YB: Upregulated miR-101 inhibits acute kidney injury-chronic kidney
disease transition by regulating epithelial-mesenchymal transition.
Hum Exp Toxicol. 39:1628–1638. 2020. View Article : Google Scholar : PubMed/NCBI
|
